Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
about
Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network BiologyNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Precision medicine for disease modification in Parkinson disease.Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease.
P2860
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@en
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@nl
type
label
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@en
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@nl
prefLabel
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@en
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@nl
P2093
P2860
P356
P1476
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
@en
P2093
Allison K Graebner
Bernard Ravina
Cornelia Kamp
David K Simon
G Webster Ross
Joanne Clark-Matott
John C Morgan
Jordan Elm
Liana Baker
NINDS NET-PD Investigators
P2860
P304
P356
10.3233/JPD-150666
P577
2015-10-03T00:00:00Z